Why the study?
Does insulin infusion alter lipoprotein cholesterol distribution in normal, normolipemic human subjects?
Does insulin infusion alter lipoprotein cholesterol distribution in normal, normolipemic human subjects?
Insulin infusion during euglycemia appears to favorably alter cholesterol distribution by increasing the HDL/total cholesterol and HDL/LDL ratios in normal subjects.
Acute insulin may raise HDL ratios in normolipemic subjects; leaves open translation to clinical outcomes or dysmetabolic states.
The role of insulin in the regulation of lipoprotein cholesterol distribution was studied in 18 human volunteers who were of normal weight, normolipemic, and glucose-tolerant. We used the euglycemic clamp technique and made comparisons with six saline-infused controls. While total cholesterol and low density lipoprotein cholesterol levels fell similarly by 6 hours in both groups (p = NS), there was a greater decrease in triglyceride levels (p less than 0.02) but less decrease in high density lipoprotein cholesterol levels (p less than 0.02) in the insulin-infused group. These changes resulted in both a higher high density lipoprotein cholesterol/total cholesterol ratio (p = 0.01) and a higher high density lipoprotein cholesterol/low density cholesterol ratio (p = 0.02) in the insulin-infused group. The timing of this effect of insulin implies a mechanism unrelated to high density lipoprotein turnover. Thus, insulin infusion during euglycemia appears to alter cholesterol distribution favorably in normal subjects.
No takes yet. Share an insight, caveat, or question.
Sadur et al. (1983) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: